NCT06891612

Brief Summary

Forgetfulness has long been considered a pathology of memory. However, the brain's voluntary suppression of certain unpleasant memories is essential for building a healthy memory. This suppression capacity can be measured using the "Think/No-Think" (TNT) paradigm.However, while the areas involved in these processes of suppression are now well described, the nature and temporal dynamics of the processes of inhibition and orientation of attention is still poorly defined. The aim of this study is to describe the nature of the attentional and inhibitory mechanisms involved in the suppression of emotionally negative memories, and their temporal articulation using electroencephalography (EEG). To this end, we will use a model of memory deletion derived from a perceptual attentional task and simulating the deletion phase in order to control the nature and timing of the processes involved. This approach will allow us to observe the presence of correspondences between the responses measured during the attentional test simulating the suppression and the actual phase of suppression, for which we cannot control the nature of the operations undertaken by the subject. In addition, we will assess the emotional response through physiological measures of autonomic nervous system activity (heart rate and electrodermal response) immediately after the TNT phase or one day later, which will allow us to evaluate the influence of memory suppression mechanisms on their emotional content. From a practical point of view, this study is organized into 3 groups of participants (healthy young adults). Each group will perform a perceptual attentional test and a TNT task, which will be preceded and followed by a measure of emotional response. Group 1 will allow us to test our main hypothesis from a behavioral point of view, as well as to calibrate the attentional task and its consistency with the TNT task. Group 2 will carry out the same tests but during an EEG examination to decode the temporal dynamics of attention states during the process of memory suppression. Group 3 will perform these same tests with a 24-hour interval between the TNT phase and the emotional assessment to estimate the effect of a retention period on forgetfulness functions. The description of these mechanisms and their physiological correlates will allow us to better understand how this ability to voluntarily control the flow of thoughts associated with negative memories is implemented, and thus to better understand the alterations in this capacity that can be observed during certain mental pathologies such as anxiety or depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2019

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 24, 2025

Completed
Last Updated

September 3, 2025

Status Verified

March 1, 2025

Enrollment Period

2.8 years

First QC Date

March 12, 2025

Last Update Submit

September 1, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Completion psychopathological scales

    Entered into a computer

    Inclusion visit

  • Measurement of the electrodermal conductance

    For emotional evaluation when presenting negative images

    Day1

  • Measuremet of heart rate

    For emotional evaluation when presenting negative images

    Day 1

Secondary Outcomes (5)

  • Attentional task

    Day 1 and Day 2

  • Test of "Think/No-Think"

    Day1 and Day2

  • Measurement of the electrodermal conductance

    Day 1 and Day 2

  • Measuremet of heart rate

    Day 1 and Day 2

  • Measurement of electroencephalographic activity

    Day1 and Day 2

Study Arms (3)

pretest healthy participants

EXPERIMENTAL
Behavioral: Cognitive AssessmentsDevice: Eye-trackingDevice: Electroencephalography (EEG)Device: Electrocardiography (ECG)

healthy participant 10 min delayed recall

EXPERIMENTAL

10 min delayed recall

Behavioral: Cognitive AssessmentsDevice: Eye-trackingDevice: Electroencephalography (EEG)Device: Electrocardiography (ECG)

healthy participant 24 h delayed recall

EXPERIMENTAL

24 h delayed recall

Behavioral: Cognitive AssessmentsDevice: Eye-trackingDevice: Electroencephalography (EEG)Device: Electrocardiography (ECG)

Interventions

Cognitive Assessments

healthy participant 10 min delayed recallhealthy participant 24 h delayed recallpretest healthy participants

measurement of the points of gaze

healthy participant 10 min delayed recallhealthy participant 24 h delayed recallpretest healthy participants

Electrophysiological monitoring method to record electrical activity of the brain

healthy participant 10 min delayed recallhealthy participant 24 h delayed recallpretest healthy participants

measurement of the electrical activity of the heart

healthy participant 10 min delayed recallhealthy participant 24 h delayed recallpretest healthy participants

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female aged between 18 and 35 years
  • Affiliated to a social security scheme
  • Having French as their mother tongue
  • Right-handed
  • High school graduate or equivalent
  • Having signed a written informed consent

You may not qualify if:

  • Pregnancy in progress, pregnancy test will be performed
  • Person deprived of liberty by judicial or administrative decision
  • Person hospitalized without consent and not subject to legal protection measures, and person admitted to a health or social care facility for purposes other than research
  • Minor
  • Adults subject to legal protection measure (guardianship, curatorship or judicial protection), adults unable to express their consent and not subject to protection measure
  • History of a neurological, psychiatric disorders, or head trauma with loss of consciousness for more than an hour
  • History of cancer over the last 5 years, with the exception of squamous cell carcinomas of the skin
  • Presence or history of chronic alcoholism or drug addiction
  • Taking medications that may alter cognitive and/or brain function (decision of the principal investigator)
  • Presence of visual and/or auditory disorders sufficiently significant to affect the progress of the tests
  • Contraindications to electroencephalography
  • Presentation of unpleasant images that are too emotionally disturbing for the participant (by decision of the physician)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de neurologie CHU de Caen

Caen, 140330 Caen Cedex 9, France

Location

Related Publications (1)

  • Legrand N, Etard O, Vandevelde A, Pierre M, Viader F, Clochon P, Doidy F, Peschanski D, Eustache F, Gagnepain P. Long-term modulation of cardiac activity induced by inhibitory control over emotional memories. Sci Rep. 2020 Sep 14;10(1):15008. doi: 10.1038/s41598-020-71858-2.

    PMID: 32929105BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepression

Interventions

Eye-Tracking TechnologyElectroencephalographyElectrocardiography

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Eye Movement MeasurementsDiagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisDiagnostic Techniques, NeurologicalHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 24, 2025

Study Start

June 13, 2016

Primary Completion

April 12, 2019

Study Completion

April 12, 2019

Last Updated

September 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations